FarmavitaR+

Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family

Drug targets are the critical link between drugs and their role in the treatment of medical disorders. By grouping drug targets into key protein families, this report provides a comprehensive analysis of the prescription pharmaceutical market by not just molecule type and therapy area, but also by target family.

Datamonitor has identified three fundamental dimensions that describe a product’s position within the pharma space—molecule type, therapy area and target type. Analysis of sales across these dimensions reveals key attractiveness characteristics that drive performance.

The target type acted on by a product dictates its standing against these key characteristics. Products acting on ECS targets tend to rate most highly and will outperform those acting on other target types. Conversely, products addressing ion channels or nuclear receptors rate poorly and face an overall decline across 2006–12.

The arrival of monoclonal antibody and therapeutic protein technologies allowed ECS targets to be exploited, expanding the ‘druggable’ target space and driving sales growth across 2006–12. Beyond 2012, further technological revolutions will, however, be required if the success experienced by these product classes is to be repeated.

Read more...